Bryant Furlow

Dr Sue Yom discusses the evolution and future of stereotactic body radiotherapy.

The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.

ASTRO has taken a lead in advising radiotherapy centers on how to manage staff and patient safety. In this column, ASTRO discusses the changes influenced by the COVID-19 pandemic.

A decade since the first wave of mobile device health apps hit the market there remain few designed specifically for patients who are undergoing radiation therapy for cancer. This review offers some useful tools available for patient education, organization, and coping.

Severe acute oral mucositis in patients undergoing radiation therapy for head and neck cancer may be associated with an increased risk of developing trismus.

This review seeks to shed light on a relatively common but poorly understood adverse effect of radiotherapy for primary and metastatic brain or head and neck tumors.

Researchers noted that bridging while awaiting CAR-T manufacturing may not be appropriate for all patients, and in some cases, bridging was associated with worse PFS and OS.

This review discusses nutritional interventions and management of nutritional status in elderly patients with cancer.

Despite widespread use of other forms of radiation therapy, consensus statements from SGO and ABS support the use of brachytherapy in the treatment of primary and recurrent cervical cancer.

In this systematic review, researchers analyzed the cost effectiveness of various treatments and treatment lines for multiple myeloma.